Who
Kimberly Park
Director
Company insider
Files Form 4 as: Director, Corcept Therapeutics.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $6.5M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 17 Sep 2019
- Last trade
- 26 Aug 2026
- Last filed
- 28 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Aug 2026filed 28 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $405K30,000 at $13.49 | filing |
| 26 Aug 2026filed 28 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code F | $405K3,315 at $122.09 | filing |
| 26 Aug 2026filed 28 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $3.3M26,685 at $122.55 | filing |
| 26 Aug 2026filed 28 Aug 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —30,000 at $0.00 | filing |
| 26 Aug 2026filed 28 Aug 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —30,000 at $0.00 | filing |
| 26 Aug 2026filed 28 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $405K30,000 at $13.49 | filing |
| 26 Aug 2026filed 28 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code F | $405K3,315 at $122.09 | filing |
| 26 Aug 2026filed 28 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $3.3M26,685 at $122.55 | filing |
| 21 May 2026filed 26 May 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 19 May 2023filed 23 May 2023 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 31 May 2022filed 2 Jun 2022 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 26 May 2021filed 28 May 2021 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 27 May 2020filed 29 May 2020 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 17 Sep 2019filed 18 Sep 2019 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
News
Corcept Therapeutics (NASDAQ:CORT) Stock Falls 14.5% – Should You Sell?CORT · themarketsdaily.com · 23 Oct 2026Corcept Therapeutics (NASDAQ:CORT) vs. Ovid Therapeutics (NASDAQ:OVID) Head-To-Head ContrastCORT · themarketsdaily.com · 15 Oct 2026
0 headlines in the last 90 days name Kimberly Park; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.